Pilot liquid emulsion for asthma
This article was originally published in The Tan Sheet
Executive Summary
Airozin medical food for dietary maintenance of asthma is slated to launch April 7 at supermarkets, drugstores in the Carolinas, Pilot says. AC Nielsen will test direct and retail marketing to gauge success, firm notes. Airozin launch has been postponed twice, most recently due to flavor reformulation; product now is a mint, rather than citrus-flavored, liquid emulsion. Previously, the Charleston, S.C.-based firm delayed launch plans while awaiting the completion of clinical trials supporting product's efficacy (1"The Tan Sheet" Nov. 4, 2002, p. 16). Two studies, one on Airozin's safety and pharmacokinetics, are slated for publication in the March Clinical Therapeutics. Firm is sponsoring Charleston Asthma Summit April 10 to educate physicians, pharmacists, advocacy groups on asthma management...
You may also be interested in...
Pilot’s Airozin Medical Food For Asthma To Launch By Year End
Pilot Therapeutics plans to introduce its asthma maintenance therapy, Airozin, by the end of 2002 after a six-month delay, the company said
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.